Detailed information
| LncRNA Name | H19 |
| Variant Type | SNP |
| Variant ID | rs217727 |
| Species | human |
| Circulating | ✕ |
| Survival | ✕ |
| CeRNA | ✕ |
| Methylation | ✕ |
| Enhancer | ✕ |
| Drug | ✕ |
| Disease/Trait | bladder cancer |
| LncRNA Target Gene | NA |
| Tissue | blood |
| Experiment | qPCR etc. |
| Function Description | A significantly decreased risk of bladder cancer was found for the rs2839698 TC genotype, but not for CC homozygotes. The rs2839698 TC genotype was especially associated with a reduced risk of developing non-muscle-invasive disease. Borderline significantly decreased risks of bladder cancer were found for the rs2107425 CT genotype, but not for TT homozygotes or for T allele carriers of rs217727. Haplotype analysis did not result in stronger associations with bladder cancer compared with the single-locus analyses. An SNP polymorphism in the nonprotein-encoding H19 gene is associated with a decreased risk of developing nonmuscleinvasive bladder cancer. This association was found for only heterozygotes, not for homozygotes. |
| Pubmed ID | 18262338 |
| Year | 2008 |
| Title | Polymorphisms in the H19 gene and the risk of bladder cancer. |
| External Links | |
|---|---|
| Links For H19 | GeneCards HGNC NONCODE LncRNAWiki lncrnadb |
| Links For bladder cancer | OMIM Cosmic |
| Links For rs217727 | dbSNP ClinVar OMIM |